Evidence map›Paper›PMID 34741594›Full record

ArticleThe Journal of antimicrobial chemotherapy2022

Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain.

Rebekah Liepa, Riti Mann, Marwan Osman, Monzer Hamze, Cindy Gunawan, Mohammad Hamidian

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. The (un)successful global spread ofMicrobial genomics · 2026
    Article
  2. Article
  3. Phage-antibiotic synergy attenuatesFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Hackflex library preparation enables low-cost metagenomic profiling.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Dissemination of theMicrobiology spectrum · 2023
    Article
  9. Article
  10. Emergence and Evolution of OXA-23-Producing ST46Antibiotics (Basel, Switzerland) · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Rebekah LiepaThe iThree Institute, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Riti MannThe iThree Institute, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Marwan OsmanLaboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.ORCID 0000-0002-6235-2760
Monzer HamzeLaboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.
Cindy GunawanThe iThree Institute, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0002-2957-1347
Mohammad HamidianThe iThree Institute, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0002-3614-7261
University of Technology Sydney · AULebanese University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the genetic context of genes conferring antibiotic resistance on the carbapenem-resistant Acinetobacter baumannii Cl415, recovered in 2017 at El Youssef Hospital Centre in Akkar Governorate, North Lebanon.

methodsAntibiotic resistance phenotype for 22 antibiotics was determined using disc diffusion or MIC determination. The whole-genome sequence of Cl415 was determined using a combination of the Illumina MiSeq and Oxford Nanopore (MinION) platforms. Complete genome was assembled using Unicycler and antibiotic resistance determinants and ISs were identified using ResFinder and ISFinder, respectively.

resultsCl415 is a global clone 2 (GC2) strain and belongs to the most common STs of this clone, ST2IP and ST218OX. Cl415 is resistant to several antibiotics, including aminoglycosides and carbapenems to a high level. Genomic analysis of Cl415 revealed that it carries four chromosomal AbaR4 copies. One copy was found in the comM gene replacing the AbGRI1 island. Cl415 also contains a novel variant of AbGRI2, herein called AbGRI2-15, carrying only the blaTEM and aphA1 resistance genes. Cl415 belongs to a subclade of GC2 strains that appear to have diverged recently with a wide geographical distribution.

conclusionsThe resistance gene complement of Cl415 was found in the chromosome with four oxa23 located in AbaR4 copies and the remaining genes in a novel variant of the AbGRI2 resistance island. Cl415 was isolated in Lebanon, but phylogenetic analysis suggests that Cl415 represents a new lineage with global distribution within GC2.

Indexed as

Acinetobacter baumanniiAminoglycosidesAnti-Bacterial AgentsCarbapenemsClone CellsPhylogenyAminoglycosidesAnti-Bacterial AgentsCarbapenems

Identifiers

PMID34741594
PMCPMC8809195
OpenAlexW3214104032

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.